TABLE 1.
HPV+ HNC | HPV− HNC (control) | |
---|---|---|
Total patients | 60 | 17 |
Sex (M/F) | 49/11 | 15/2 |
Median age (range) | 66 (42–84) | |
Primary/recurrent | 55/5 a | N/A |
Plasma available | 55/60 patients | 17/17 patients |
Saliva available | 57/60 patients | 14/17 patients |
Treatment |
Chemotherapy and surgery: 42 patients Chemoradiation: 14 patients Other: 4 patients |
N/A |
One patient was additionally sampled for later recurrence following primary disease.